We serve Chemical Name:tert-butyl N-[(3S)-azepan-3-yl]carbamate CAS:213990-48-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-butyl N-[(3S)-azepan-3-yl]carbamate
CAS.NO:213990-48-8
Synonyms:tert-butyl N-[(3S)-azepan-3-yl]carbamate
Molecular Formula:C11H22N2O2
Molecular Weight:214.30500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:53.85000
Exact Mass:214.16800
LogP:2.18640
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like tert-butyl N-[(3S)-azepan-3-yl]carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl N-[(3S)-azepan-3-yl]carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl N-[(3S)-azepan-3-yl]carbamate Use and application,tert-butyl N-[(3S)-azepan-3-yl]carbamate technical grade,usp/ep/jp grade.
Related News: Findings show that there is a decline in the body’s immunity over time. The aim of the supplementary dose is to build it up again, and thus reduce the chances of infection and serious illness significantly,” Bennett told a news conference.
“I call on all the seniors who received the second dose, go get the supplementary one,” he said. “My first telephone call, after I finish speaking, will be to the person dearest to me, my mother, so that I can take her to be vaccinated immediately. (R)-N-(3-(4-amino-3,5-bis(trifluoromethyl)phenyl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2,4,5-tetrahydro-3H-benzo[d][1,3]diazepin-3-yl)piperidine-1-carboxamide manufacturers In addition, the government has made a series of new commitments, including: 3-(benzo[c][1,2,5]thiadiazol-5-yl)-4-(4-(hexyloxy)benzyl)-5-hydroxy-5-(4-methoxyphenyl)furan-2(5H)-one suppliers After speaking to iRhythm on Tuesday, J.P. Morgan analysts wrote we shouldn’t expect an update on reimbursement before the release of the Physician Fee Schedule proposed rule in July/August. methyl (4R,4aR,6aS,10bR,10cS)-11-acetoxy-9b-isopropyl-4,10c-dimethyl-8-oxotetradecahydro-1H-7,10-methanobenzo[4,5]cyclopropa[2,3]indeno[1,7a-b]furan-4-carboxylate vendor & factory.
“I call on all the seniors who received the second dose, go get the supplementary one,” he said. “My first telephone call, after I finish speaking, will be to the person dearest to me, my mother, so that I can take her to be vaccinated immediately. (R)-N-(3-(4-amino-3,5-bis(trifluoromethyl)phenyl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2,4,5-tetrahydro-3H-benzo[d][1,3]diazepin-3-yl)piperidine-1-carboxamide manufacturers In addition, the government has made a series of new commitments, including: 3-(benzo[c][1,2,5]thiadiazol-5-yl)-4-(4-(hexyloxy)benzyl)-5-hydroxy-5-(4-methoxyphenyl)furan-2(5H)-one suppliers After speaking to iRhythm on Tuesday, J.P. Morgan analysts wrote we shouldn’t expect an update on reimbursement before the release of the Physician Fee Schedule proposed rule in July/August. methyl (4R,4aR,6aS,10bR,10cS)-11-acetoxy-9b-isopropyl-4,10c-dimethyl-8-oxotetradecahydro-1H-7,10-methanobenzo[4,5]cyclopropa[2,3]indeno[1,7a-b]furan-4-carboxylate vendor & factory.